Jefferies Financial Group lowered shares of ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) from a buy rating to a hold rating in a research report released on Thursday, The Fly reports. Jefferies Financial Group also issued estimates for ASPEN PHARMACAR/ADR’s FY2024 earnings at $1.06 EPS.
APNHY has been the subject of several other reports. ValuEngine downgraded ASPEN PHARMACAR/ADR from a hold rating to a sell rating in a report on Monday, November 25th. Zacks Investment Research lowered ASPEN PHARMACAR/ADR from a hold rating to a sell rating in a research report on Monday, November 18th.
Shares of OTCMKTS:APNHY opened at $7.43 on Thursday. The stock has a fifty day simple moving average of $7.54 and a two-hundred day simple moving average of $6.56. ASPEN PHARMACAR/ADR has a 12-month low of $4.14 and a 12-month high of $11.36.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.
Featured Article: 12b-1 Fees
Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.